Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Citi
Express Scripts
Federal Trade Commission
Cipla
Teva
Moodys
Harvard Business School

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009987

« Back to Dashboard

NDA 009987 describes DELTA-CORTEF, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the DELTA-CORTEF profile page.

The generic ingredient in DELTA-CORTEF is prednisolone. There are eighty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the prednisolone profile page.
Summary for 009987
Medical Subject Heading (MeSH) Categories for 009987

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Deloitte
UBS
Citi
Johnson and Johnson
Teva
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.